Open forum infectious diseases · 2026
Acceptability of a Chlamydia Vaccine Among Young Women and Men in Birmingham, Alabama, USA: 2023-2025.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gupta Kanupriya, Gamble Bria I, D'Amico Madison J, Pentala Aamuktha, Hu Muhan, Shiry Rebecca J, Aaron Kristal J, Arbuckle Janeen L, Hill Samantha V, Van Der Pol Barbara, Geisler William M
Аннотация
BACKGROUND: Chlamydia infection remains a global health concern, justifying the need for a chlamydia vaccine. Chlamydia infection rates are highest among young women and men; thus, they would be the target populations for vaccination. However, vaccine availability does not ensure uptake. We conducted a survey among youth to identify factors that may influence chlamydia vaccine acceptability.
METHODS: Females and males aged 16-29 years seen for care in adolescent, gynecology, student health, and sexual health clinics completed a computer-assisted survey, collecting information on sexual health, health care utilization, vaccination history, and factors related to chlamydia and vaccine acceptability.
RESULTS: Of 399 female and 221 male participants, most (93.2%) had heard of chlamydia, 28.1% reported prior chlamydia infection, and 52.6% believed they could acquire chlamydia infection. Interest in chlamydia vaccination was reported by 42.4% females and associated with non-Black race, Hispanic ethnicity, clinic site, previous influenza or COVID-19 vaccination, and awareness of human papillomavirus vaccination. Among males, 44.8% reported chlamydia vaccination interest that was associated with ethnicity, human papillomavirus vaccine awareness, chlamydia awareness, prior chlamydia infection, and possibility of acquiring chlamydia infection. Among all participants, most (82.5%) reported their main motivation for vaccination was to protect themselves and major barriers were concerns about safety (50.0%) and cost (23.1%). The majority (66.0%) reported health care providers as the main resource for vaccine information and were more likely to get vaccinated if recommended by them.
CONCLUSIONS: Less than half of surveyed youth were interested in receiving a chlamydia vaccine. Findings will guide strategies for chlamydia vaccine implementation.
METHODS: Females and males aged 16-29 years seen for care in adolescent, gynecology, student health, and sexual health clinics completed a computer-assisted survey, collecting information on sexual health, health care utilization, vaccination history, and factors related to chlamydia and vaccine acceptability.
RESULTS: Of 399 female and 221 male participants, most (93.2%) had heard of chlamydia, 28.1% reported prior chlamydia infection, and 52.6% believed they could acquire chlamydia infection. Interest in chlamydia vaccination was reported by 42.4% females and associated with non-Black race, Hispanic ethnicity, clinic site, previous influenza or COVID-19 vaccination, and awareness of human papillomavirus vaccination. Among males, 44.8% reported chlamydia vaccination interest that was associated with ethnicity, human papillomavirus vaccine awareness, chlamydia awareness, prior chlamydia infection, and possibility of acquiring chlamydia infection. Among all participants, most (82.5%) reported their main motivation for vaccination was to protect themselves and major barriers were concerns about safety (50.0%) and cost (23.1%). The majority (66.0%) reported health care providers as the main resource for vaccine information and were more likely to get vaccinated if recommended by them.
CONCLUSIONS: Less than half of surveyed youth were interested in receiving a chlamydia vaccine. Findings will guide strategies for chlamydia vaccine implementation.